Advertisement

Topics

EUROPE OPHTHALMIC DRUGS DEVICES MARKET FORECAST 20172025 [Updated: 01062017] Prices from USD $1250

13:44 EDT 19 Jun 2017 | BioPortfolio Reports

KEY FINDINGS
Europe ophthalmic drugs devices market was valued at $15026.32 million in 2016 and is expected to reach $24132.02 million by 2025 growing at a CAGR of 5.43% during the forecast period of 20172025. The ophthalmic drugs and devices market is driven by an increase in FDA approvals which gives a boost in the adoption of drugs and devices and rise in surgeries in ophthalmology market due to the high dominance of refractive errors.
MARKET INSIGHTS
The AsiaPacific ophthalmic drugs devices market is segmented by ophthalmic devices, surgery devices, vision care, by type of diseases, by therapeutics and by geography atrophy. Globally increase in geriatric population, rise in the number of eye disorders, increase in healthcare expenditure and rise in adoption of minimally invasive surgeries have contributed to the growth of the market.
Wellknown drugs are going off patent and key players affected by the delay in new drugs coming into the market are the two factors restricting the growth of the market. The market faces challenges in risk associated with the ocular diseases and lack of awareness among people regarding ophthalmology.
COMPETITIVE INSIGHTS
Global ophthalmic drugs market has a large number of market players but the market is dominated by companies like Novartis AG and Santen.
1. ABBOTT LABORATORIES
2. AKORN
3. ALLERGAN INC.
4. BAYER AG
5. CIPLA PHARMACEUTICALS
6. EYEGATE PHARMACEUTICALS
7. EYEMED
8. GLAXOSMITHKLINE
9. JOHNSON AND JOHNSON
10. LPATH INCORPORATED
11. MERCK CO.
12. BIOTECH VISIONCARE
13. CARL ZEISS MEDIATEK AG
14. ELLEX
15. NIDEK CO. LTD
16. NOVARTIS AG
17. PFIZER INC.
18. REGENERON
19. ROCHE HOLDING AG
20. SENJU PHARMACEUTICAL CO., LTD
21. SUN PHARMACEUTICALS INDUSTRIES, LTD.
22. SANTEN PHARMACEUTICAL CO.LTD
23. STAAR SURGICAL COMPANY
24. TOPCON CORPORATION
25. VALEANT
26. VISIONCARE OPHTHALMIC TECHNOLOGIES
27. ZIEMER OPHTHALMIC SYSTEMS AG
28. HAAGSTREIT GROUP
29. IRIDEX CORPORATION

Original Article: EUROPE OPHTHALMIC DRUGS DEVICES MARKET FORECAST 20172025 [Updated: 01062017] Prices from USD $1250

NEXT ARTICLE

More From BioPortfolio on "EUROPE OPHTHALMIC DRUGS DEVICES MARKET FORECAST 20172025 [Updated: 01062017] Prices from USD $1250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...